Using Simulation and Decision Modeling to Inform Decision Making AHRQ Annual Meeting Sept. 8, 2008.

Slides:



Advertisements
Similar presentations
Panel Management, Applying Population Health and Best Evidence Paige Hatcher, MD - Diplomate, ABFM - Preventive Medicine Resident, OHSU - MPH Candidate,
Advertisements

CANCER SCREENING 2011 DELAWARE CANCER EDUCATION ALLIANCE STEPHEN S. GRUBBS, M.D. HELEN F. GRAHAM CANCER CENTER DELAWARE CANCER CONSORTIUM OCTOBER 5, 2011.
Basic Statistics: The Three Things You Need to Know In Order to Complete Your Project.
Neurological Predictors of Huntington’s Disease
Validation Study of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Amylou C. Dueck (Mayo Clinic)
Mary Barton, MD, MPP Vice President, Performance Measures “Balancing scientific and social dimensions of guidelines”
UPenn Prevention Research Center’s CPCRN Collaborating Center University of Pennsylvania (UPenn) Prevention Research Center is a new PRC, Principal.
Developed through the APTR Initiative to Enhance Prevention and Population Health Education in collaboration with the Brody School of Medicine at East.
Sixth Annual Meeting March 12, :00am to 4:00pm Crowne Plaza National Airport Arlington, VA INTERMACS Annual Meeting March 2012.
A-1 Pravastatin-Aspirin Introduction Todd Baumgartner, MD, MPH Vice President Regulatory Sciences Pharmaceutical Research Institute Bristol-Myers Squibb.
Economic Evaluation of Cancer Screening - Case of Colorectal Cancer – Cost-Effectiveness analysis of stool DNA to Screen for Colorectal Cancer October.
Clinical Practice Screening for Colorectal Cancer David A. Lieberman, M.D. N Engl J Med Volume 361(12): September 17, 2009.
Geriatric Health Maintenance: Cancer Screening Linda DeCherrie, MD Geriatric Fellow Mount Sinai Hospital.
Cancer Program Fewer Montanans experience late stage cancer. Fewer Montanans die of cancer. Metrics Biannual percent of Montanans who are up-to-date with.
Acute Ischemic Stroke Management: 2004 Emergency Medicine Perspectives.
A Cervical Cancer Decision Model to Inform Recommendations About Preventive Services Perspective of the Decision Modeler Shalini Kulasingam, PhD Duke University.
How to Overcome Barriers and Develop Collaborative Guidelines Amir Qaseem, MD, PhD, MHA, FACP Chair, Guidelines International Network Director, Clinical.
ARC NW Alliance for Reducing Cancer Northwest Boston November, 2007.
Science at the FDA: Update for the Science Board Jesse L. Goodman, MD, MPH Chief Scientist and Deputy Commissioner for Science and Public Health November.
Decision Analysis of Colorectal Cancer Screening Tests by Age to Begin, Age to End, and Screening Intervals: Report to the United States Preventive Services.
Research Design: The Progression of Study Designs that Address a Clinical Question.
Comprehensive Cancer Control Planning Telling New Jersey’s Story Peg Knight, RN, M.Ed. Executive Director Office of Cancer Control and Prevention New.
Why Screening? Improvement Facilitator Training Session 1 Day 1.
Joe Selby, MD MPH EBRI December 15, 2011 What Might Patient (Employee)- Centered Research Look Like?
Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute.
Colorectal Cancer (CRC) Surveillance: Introduction and Overview Carrie Klabunde, Ph.D. IBSN Biennial Meeting Ottawa, Canada May 11-12, 2006.
Todays Clinical Trials. Tomorrow’s Cures. Robert L. Comis, MD 1 National Coalition for Cancer Research “Cancer 101” Congressional Briefing 09/10/14.
USPSTF: Perspectives of a Member Diana Petitti, MD, MPH September 7, 2008 AHRQ “Lunch and Learn”
Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.
AHRQ’s Patient Safety and Medical Liability Initiative James B. Battles, Ph.D. Agency for Healthcare Research and Quality Center for Quality Improvement.
West Virginia Clinical Translational Science Institute Links Scientists and Teachers Sara Hanks, Ann Chester, Summer Kuhn.
Evidence Review Group: Past to Present James M. Perrin, MD Professor of Pediatrics, Harvard Medical School MGH Center for Child and Adolescent Health Policy.
Secondary Translation: Completing the process to Improving Health Daniel E. Ford, MD, MPH Vice Dean Johns Hopkins School of Medicine Introduction to Clinical.
Setting a Culture for Innovation Penn Medicine Center for Health Care Innovation Shivan Mehta, MD, MBA Assistant Professor of Medicine, Division.
Joni Reynolds, RN-CNS, MSN Director of Public Health Programs Winnable Battles: Cancer in Colorado.
Medical Knowledge Systems. What are they? As with many things in life there are a few different approaches to medical knowledge. Think of it like different.
LSU Journal Club Should Colorectal Cancer Screening be Considered in Elderly Persons without Previous Screening? Claude Pirtle, PGY-I October 16th, 2014.
Shared Decision Making: Helping Patients be Partners in Their Care 2009 AHRQ Annual Meeting September 14, 2009.
Modeling Efforts to Inform Countries’ Screening Decisions Ann Graham Zauber, Iris Vogelaar, Marjolein van Ballegooijen, Deb Schrag, Rob Boer, Dik Habbema,
Type Your Title Here Author’s First Name Last Name, degree,…. Mentor’s First Name Last Name, degree Dept. Name here, NYU Lutheran Medical Center, Brooklyn,
Chlamydia: Reported Cases, Rates, and Screening in Midwest States Tandra R. Gordon, M.S., 1 Brian C. Gordon, PhD, 2 and Lori W. Turner, PhD 2 Southern.
Edward P. Sloan, MD, MPH Grant Opportunities in Emergency Medical Services & Bioterrorism Preparedness.
AHRQ annual meeting September 10, 2008 Stephanie Chang MD, MPH Center for Outcomes and Evidence Conducting a methodologically sound systematic review with.
Primary Care Improvement Infrastructure: The Role of Practice Facilitation Michael L. Parchman, MD MPH MacColl Center for Health Care Innovation AHRQ Annual.
This presentation was supported by Cooperative Agreement Numbers U48-DP001909, U48-DP001946, U48-DP001924, U48-DP001934, U48-DP001938(03), U48-DP001944,
1 Maximizing the Impact of Comparative Effectiveness Research: The Role of the DEcIDE Consortia Scott R. Smith, PhD AHRQ Center for Outcomes & Evidence.
D EPARTMENT of F AMILY M EDICINE Colorectal Cancer Screening: Update on Guidelines and Projects Barcey T. Levy, PhD, MD Professor, Department of Family.
Cardiovascular Consortium Effective Health Care Program Art Sedrakyan, MD, PhD Center for Outcomes & Evidence, AHRQ.
Department of Family and Community Medicine Measuring up to the common core: What is known about the delivery of primary care in school-based health centers.
Do Decision Aids Promote Shared Decision-Making for Prostate Cancer Screening? Alex Krist MD Steven Woolf MD MPH Robert Johnson PhD Department of Family.
System Improvement for Age and Gender-Appropriate Health Screening Practices Lisa Aldrich, BSN, RN Doctor of Nursing Practice Candidate Ann Marie Hart,
System Improvement for Age and Gender-Appropriate Health Screening Practices Lisa Aldrich, BSN, RN, Doctor of Nursing Practice Student; Ann Marie Hart,
Date of download: 7/1/2016 From: Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal- Cancer Deaths N ENG J MED ;8 : Ann G. Zauber, Ph.D, Sidney J. Winawer,
Health Literacy Summit Madison, WI
Learning Health Systems: Working at the Intersection of Research, Operations and Big Data Welcome May 5, 2017.
Colorectal Cancer Screening Guidelines
Florida’s Top 5 Causes of Deaths
CPCRN Cervical Cancer Workgroup Presentation
Idealized Natural A Systematic Yet Flexible Systems Analysis Framework
From: Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations: Methods of the U.S. Preventive Services.
What Are Clinical Trials?
Behavioral Sciences and Social Medicine
Dr.farahani MD-Mph Arak health center
The Research Question What is the evidence on diagnostic test performance and clinical outcomes of supplemental screening of women with dense breasts with.
PCORI Research Priorities and Relevant Examples
Trends in Subpopulations at High Risk for Lung Cancer
Lessons Learned from the Mistakes of Others
April 18th 2018 Moderator: Matthew Rioth
Presentation transcript:

Using Simulation and Decision Modeling to Inform Decision Making AHRQ Annual Meeting Sept. 8, 2008

This Morning’s Session Can Clinical Trials really answer all relevant questions? Can Clinical Trials really answer all relevant questions? – What if the patient is older/younger/sicker/ better/etc. than in the trials? – What if the technology has changed? – What if management strategy has changed? Can simulation modeling help fill in the gaps? Can simulation modeling help fill in the gaps?

From the Modeler’s Side Many decision models in the literature Many decision models in the literature – Single use “one off” models – More global natural history models designed for wide range of questions Can decision models inform decisions? Can decision models inform decisions? – Working with the decision makers to determine Relevant alternatives and inputs Relevant alternatives and inputs Relevant outcomes Relevant outcomes – Case study today of working with the US Preventive Services Task Force to examine Cancer Screening

Today’s Agenda Diana Petitti, MD, MPH (briefly) Diana Petitti, MD, MPH (briefly) Professor of Biomedical Informatics, Arizona State University Vice Chair, USPSTF Author of Meta-Analysis, Decision Analysis, and Cost- Effectiveness Analysis Ann Zauber, PhD Ann Zauber, PhD Memorial Sloan-Kettering Cancer Center, NY Coordinator of CISNET Colorectal Cancer Modeling Groups Shalini Kulasingam, PhD Shalini Kulasingam, PhD University of Minnesota Investigator on the Duke Cervical Cancer Model Diana Petitti Diana Petitti

Zauber Zauber Kulasingam Kulasingam Petitti Petitti